Decreased androgen-responsive growth of human prostate cancer is associated with increased genetic alterations

Clinical Cancer Research

Volumn 7, Issue 11, 2001, Pages 3472-3480

  Karan, D ^a   Schmied, B M ^a   Dave, B J ^a   Wittel, U A ^a   Lin, M F ^a   Batra, S K ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; DNA MARKER; MICROSATELLITE DNA;

ALLELE; ANIMAL CELL; ARTICLE; CHROMOSOME 3; CHROMOSOME LOSS; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE RESPONSE; HUMAN; HUMAN TISSUE; KARYOTYPE; MALE; MICROSATELLITE INSTABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR GROWTH; Y CHROMOSOME;

ANDROGENS; ANIMALS; CELL DIVISION; DNA, NEOPLASM; FEMALE; HUMANS; KARYOTYPING; LOSS OF HETEROZYGOSITY; MALE; MICE; MICE, NUDE; MICROSATELLITE REPEATS; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0035175919     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Androgen receptor gene and hormonal therapy failure of prostate cancer
2. Orchiectomy for advanced prostatic carcinoma. A reevaluation
3. Carcinoma of the prostate
4. Microsatellite instability in human solid tumors
5. Genetic instabilities in human cancers
6. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
7. Induction of microsatellite instability by oxidative DNA damage
8. Defects of DNA mismatch repair in human prostate cancer
9. DNA mismatch repair enzyme activity and gene expression in prostate cancer
10. The mismatch repair gene hMSH2 is mutated in the prostate cancer cell line LNCaP
11. Chromosomal clues to the development of prostate tumors
12. Cytogenetic analysis of 39 prostate carcinomas and evaluation of short-term tissue culture techniques
13. Cytogenetic analysis of 57 primary prostatic adenocarcinomas
14. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization
15. Infrequent RAS oncogene mutations in human prostate cancer
16. A heterogeneous pattern of progression in endocrine-treated patients with prostate cancer
17. Morphologic and immunologic studies of human prostatic carcinoma
18. Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines
19. LNCaP model of human prostatic carcinoma
20. Chromosome banding techniques
21. Transfection of the human Muc 1 mucin gene into a poorly differentiated human pancreatic tumor cell line, Panc1: Integration, expression and ultrastructural changes
22. A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
23. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts
24. Cytogenetic survey of 32 cancers of the prostate
25. Frequency and pattern of karyotypic abnormalities in human prostate cancer
26. Cytogenetics of primary prostatic adenocarcinoma. Clonality and chromosome instability
27. Chromosomal abnormalities and related events in prostate cancer
28. Y chromosome enumeration in touch preparations from 42 prostate tumors by interphase fluorescence in situ hybridization analysis
29. The genetic analysis of prostate carcinoma
30. BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines
31. Allelic profiles of mononucleotide repeat microsatellites in control individuals and in colorectal tumors with and without replication errors
32. Testing tumors for microsatellite instability
33. Polymorphic variation at the BAT-25 and BAT-26 loci in individuals of African origin. Implications for microsatellite instability testing
34. Microsatellite instability: The mutator that mutates the other mutator
35. Allelic imbalance and microsatellite instability in prostatic adenocarcinoma
36. Genetic basis and clonal evolution of human prostate cancer
37. Chromosome 3p24-26 and 3p22-12 loss in human prostatic adenocarcinoma
38. Identification of genetic markers for prostatic cancer progression
39. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21
40. Genetic alterations in incidentally diagnosed, transitional zone prostate cancer: A seven year follow-up
41. Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer
42. Identification of a I-cM region of common deletion on 13q 14 associated with human prostate cancer
43. Allelic loss at 1p34, 13q12, 17p13.3, and 17q21.1 correlates with poor postoperative prognosis in breast cancer
44. Allelic loss in chromosomal region 1q21-23 in breast cancer is associated with peritumoral angiolymphatic invasion and extensive intraductal component
45. High-resolution deletion mapping of chromosome arm 1p in pancreatic cancer identifies a major consensus region at 1p35
46. Allelic loss of the region of chromosome 1p35-pter is associated with progression of human gastric carcinoma
47. Infrequent allelic imbalance at the major susceptibility HPC1 locus in sporadic prostate tumours
48. Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43
49. Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36
50. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search